<DOC>
	<DOCNO>NCT00026039</DOCNO>
	<brief_summary>To determine estrogen hormone replacement therapy reduces risk stroke death postmenopausal woman already stroke transient ischemic attack ( TIA ) .</brief_summary>
	<brief_title>Women 's Estrogen Stroke Trial ( WEST )</brief_title>
	<detailed_description>The researcher enrol 664 postmenopausal woman average age 71 year experience ischemic stroke TIA within previous 90 day . Ischemic stroke TIAs result blockage vessel supply blood brain . Participants give number initial assessment , include NIH Stroke Scale ( NIHSS ) neurological impairment Barthel index functional ability activity daily live . In addition usual best care patient stroke , woman trial receive either oral estrogen ( estradiol 17-beta standard replacement dose 1 mg daily ) match placebo . Patients studied average 2.8 year . They stop receive estrogen placebo stroke . The researcher find significant difference incidence stroke death woman randomly assign receive estrogen instead placebo . However , find incidence death due stroke high estrogen group non-fatal stroke group associate slightly bad neurological functional impairment 1 month stroke . The risk stroke within first 6 month enrollment study also high among woman estrogen group . There significant difference treatment group number TIAs non-fatal heart attack . However , participant receive estrogen likely experience gynecologic complication , particularly vaginal bleeding .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<criteria>None</criteria>
	<gender />
	<minimum_age />
	<maximum_age />
	<verification_date>November 2005</verification_date>
	<keyword>stroke</keyword>
	<keyword>estrogen</keyword>
</DOC>